Prashant Nagre elevated to the position of MD of Fermenta Biotech

Krishna Datla, Promoter and Managing Director of Fermenta Biotech Limited (FBL) on May 6, announced the appointment of Chief Executive Officer, Prashant Nagre, as the new Managing Director with effect from 9th May 2021. Datla will continue as a Board member and the Executive Vice Chairman.

The last few years have witnessed implementation of significant strategic decisions being spearheaded by the management and Board of FBL, such as acquisition of equity shares from its earlier PE investor followed by the merger with its parent company for enhancing operational synergies. The current announcement is another such step taken by the promoters towards inculcating greater professionalization of the company to fuel its growth ambitions.

Prashant Nagre joined FBL in 2010 as the Chief Operating Officer and in two years, was elevated to the position of Chief Executive Officer. Since then, he has led corporate strategy, business operations and demand-driven innovation for FBL’s three business verticals viz., Vitamin D and other APIs, Integrated Biotechnology and Environmental Solutions. Under the leadership of Datla, during Prashant’s tenure, FBL has expanded from a solely domestic-focused business to a global vitamin player, with more than 70% of revenues now arising from exports.Prashant will also be responsible for steering the company’s efforts to foray into the nutrition segmentby developing a future-ready organization with a value-added portfolio.

(To receive our E-paper on whatsapp daily, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

Free Press Journal